Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis (original) (raw)

• Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504–1517
  Article PubMed Google Scholar
• Halfvarson J et al. (2003) Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124: 1767–1773
  Article PubMed Google Scholar
• Newman B and Siminovitch KA (2005) Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 21: 401–407
  PubMed Google Scholar
• Schreiber S et al. (2005) Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6: 376–388
  Article CAS PubMed Google Scholar
• Hugot JP et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599–603
  Article CAS PubMed Google Scholar
• Ogura Y et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603–606
  Article CAS PubMed Google Scholar
• Cario E (2005) Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 54: 1182–1193
  Article CAS PubMed PubMed Central Google Scholar
• Hisamatsu T et al. (2003) CARD15/NOD2 functions as an anti-bacterial factor in human intestinal epithelial cells. Gastroenterology 124: 993–1000
  Article CAS PubMed Google Scholar
• Barnich N et al. (2005) GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J Biol Chem 280: 19021–19026
  Article CAS PubMed Google Scholar
• Lala S et al. (2003) Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125: 47–57
  Article CAS PubMed Google Scholar
• Kobayashi KS et al. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731–734
  Article CAS PubMed Google Scholar
• Wehkamp J et al. (2005) Reduced Paneth cell α-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 102: 18129–18134
  Article CAS PubMed PubMed Central Google Scholar
• Watanabe T et al. (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5: 800–808
  Article CAS PubMed Google Scholar
• Swidsinski A et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44–54
  Article PubMed Google Scholar
• Peltekova VD et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36: 471–475
  Article CAS PubMed Google Scholar
• Noble CL et al. (2005) The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129: 1854–1864
  Article CAS PubMed Google Scholar
• Stoll M et al. (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36: 476–480
  Article CAS PubMed Google Scholar
• Ho GT et al. (2005) Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 128: 288–296
  Article CAS PubMed Google Scholar
• Brant SR et al. (2003) MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73: 1282–1292
  Article CAS PubMed PubMed Central Google Scholar
• Farrell RJ et al. (2000) High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118: 279–288
  Article CAS PubMed Google Scholar
• Panwala CM et al. (1998) A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, Mdr1a, spontaneously develop colitis. J Immunol 161: 5733–5744
  CAS PubMed Google Scholar
• Sugawara K et al. (2005) Linkage to peroxisome proliferator-activated receptor-γ in SAMP1/YitFc mice and in human Crohn's disease. Gastroenterology 128: 351–360
  Article CAS PubMed Google Scholar
• Dubuquoy L et al. (2003) Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology 124: 1265–1276
  Article CAS PubMed Google Scholar
• Rousseaux C et al. (2005) Intestinal anti-inflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ. J Exp Med 201: 1205–1215
  Article CAS PubMed PubMed Central Google Scholar
• Lewis JD et al. (2001) An open-label trial of the PPAR-γ ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol 96: 3323–3328
  CAS PubMed Google Scholar
• Su CG et al. (1999) A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383–389
  Article CAS PubMed PubMed Central Google Scholar
• Duchmann R et al. (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102: 448–455
  Article CAS PubMed PubMed Central Google Scholar
• Mow WS et al. (2004) Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126: 414–424
  Article CAS PubMed Google Scholar
• Targan SR et al. (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337: 1029–1035
  Article CAS PubMed Google Scholar
• Mannon PJ et al. (2004) Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351: 2069–2079
  Article CAS PubMed Google Scholar
• Sawada K et al. (2005) Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case–control study with sham apheresis as placebo treatment. Am J Gastroenterol 100: 1362–1369
  Article PubMed Google Scholar
• Lichtiger S et al. (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841–1845
  Article CAS PubMed Google Scholar
• Sartor RB and Hoentjen F (2005) Proinflammatory cytokines and signaling pathways in intestinal innate immune cells. In Mucosal Immunology, 681–701 (Eds Mestecky J et al.) Philadelphia: Elsevier
  Chapter Google Scholar
• Reaves TA et al. (2005) Neutrophil transepithelial migration: role of Toll-like receptors in mucosal inflammation. Mem Inst Oswaldo Cruz 100 (Suppl 1): 191–198
  Article CAS PubMed Google Scholar
• Smythies LE et al. (2005) Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66–75
  Article CAS PubMed PubMed Central Google Scholar
• Iwasaki A and Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987–995
  Article PubMed CAS Google Scholar
• Jarnerot G et al. (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128: 1805–1811
  Article PubMed CAS Google Scholar
• Neurath MF et al. (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2: 998–1004
  Article CAS PubMed Google Scholar
• Egan LJ et al. (2004) IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA 101: 2452–2457
  Article CAS PubMed PubMed Central Google Scholar
• Chen LW et al. (2003) The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia–reperfusion. Nat Med 9: 575–581
  Article CAS PubMed Google Scholar
• Araki A et al. (2005) MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 40: 16–23
  Article CAS PubMed Google Scholar
• Rakoff-Nahoum S et al. (2004) Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229–241
  Article CAS PubMed Google Scholar
• Sartor RB (2004) Animal models of intestinal inflammation. In Kirsner's Inflammatory Bowel Diseases, 120–137 (Eds Sartor RB and Sandborn WJ) Philadelphia: Elsevier
  Google Scholar
• Spencer DM et al. (2002) Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122: 94–105
  Article PubMed Google Scholar
• Bamias G et al. (2005) Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 128: 654–666
  Article CAS PubMed Google Scholar
• Kolls JK and Linden A (2004). Interleukin-17 family members and inflammation. Immunity 21: 467–476
  Article PubMed Google Scholar
• Becker C et al. (2003) Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest 112: 693–706
  Article CAS PubMed PubMed Central Google Scholar
• Fujino S et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65–70
  Article CAS PubMed PubMed Central Google Scholar
• Schmidt C et al. (2005) Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 11: 16–23
  Article PubMed Google Scholar
• Yen D et al. (2006) IL-23 is essential for T-cell mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310–1316
  Article CAS PubMed PubMed Central Google Scholar
• Monteleone G et al. (2005) Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn's disease. Gastroenterology 128: 687–694
  Article CAS PubMed Google Scholar
• Neurath MF et al. (2002) The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195: 1129–1143
  Article CAS PubMed PubMed Central Google Scholar
• Fuss IJ et al. (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157: 1261–1270
  CAS PubMed Google Scholar
• Fuss IJ et al. (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical TH2 response in ulcerative colitis. J Clin Invest 113: 1490–1497
  Article CAS PubMed PubMed Central Google Scholar
• Hart AL et al. (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129: 50–65
  Article CAS PubMed Google Scholar
• Totsuka T et al. (2003) Ameliorating effect of anti-inducible co-stimulator monoclonal antibody in a murine model of chronic colitis. Gastroenterology 124: 410–421
  Article CAS PubMed Google Scholar
• Williams IR (2004) Chemokine receptors and leukocyte trafficking in the mucosal immune system. Immunol Res 29: 283–292
  Article CAS PubMed Google Scholar
• Hosoe N et al. (2004) Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa. Am J Physiol Gastrointest Liver Physiol 286: G458–G466
  Article CAS PubMed Google Scholar
• Connor SJ et al. (2004) CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut 53: 1287–1294
  Article CAS PubMed PubMed Central Google Scholar
• Ghosh S et al. (2003) Natalizumab for active Crohn's disease. N Engl J Med 348: 24–32
  Article CAS PubMed Google Scholar
• Feagan BG et al. (2005) Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin. N Engl J Med 352: 2499–2507
  Article CAS PubMed Google Scholar
• Haller D et al. (2002) IKKβ and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-κB activation in both primary and intestinal epithelial cell lines. J Biol Chem 277: 38168–38178
  Article CAS PubMed Google Scholar
• Ruiz PA et al. (2005) IL-10 gene- deficient mice lack TGF β/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol 174: 2990–2999
  Article CAS PubMed Google Scholar
• Lodes MJ et al. (2004) Bacterial flagellin is a dominant antigen in Crohn's disease. J Clin Invest 113: 1296–1306
  Article CAS PubMed PubMed Central Google Scholar
• Targan SR et al. (2005) Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128: 2020–2028
  Article CAS PubMed Google Scholar
• Hoentjen F et al. (2005) STAT3 regulates NF-κB recruitment to the IL-12 p40 promoter in dendritic cells. Blood 105: 689–696
  Article CAS PubMed Google Scholar
• Katakura K et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115: 695–702
  Article CAS PubMed PubMed Central Google Scholar
• Kim SC et al. (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128: 891–906
  Article CAS PubMed Google Scholar
• Sellon RK et al. (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224–5231
  CAS PubMed PubMed Central Google Scholar
• Macpherson A et al. (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38: 365–375
  Article CAS PubMed PubMed Central Google Scholar
• Brandwein SL et al. (1997) Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol 159: 44–52
  CAS PubMed Google Scholar
• Mizoguchi E et al. (1997) Antineutrophil cytoplasmic antibodies in T-cell receptor alpha-deficient mice with chronic colitis. Gastroenterology 113: 1828–1835
  Article CAS PubMed Google Scholar
• Mizoguchi A (1997) Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 186: 1749–1756
  Article CAS PubMed PubMed Central Google Scholar
• Velazquez P et al. (2005) Surveillance B lymphocytes and mucosal immunoregulation. Springer Semin Immunopathol 26: 453–462
  Article PubMed Google Scholar
• Cong Y et al. (2002) Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 169: 6112–6119
  Article CAS PubMed Google Scholar
• Veltkamp C et al. (2001) Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(ε26) mice. Gastroenterology 120: 900–913
  Article CAS PubMed Google Scholar
• Kim SC et al. (2005) Different host genetic backgrounds determine disease phenotypes induced by selective bacterial colonization [abstract]. Gastroenterology 128: A512
  Google Scholar
• Bibiloni R et al. (2005) Analysis of the large bowel microbiota of colitic mice using PCR/DGGE. Lett Appl Microbiol 41: 45–51
  Article CAS PubMed Google Scholar
• Moran JP et al. (2006) Bifidobacterium animalis causes mild inflammatory bowel disease in interleukin-10 knockout mice [abstract]. Gastroenterology 130: A6
  Article Google Scholar
• Holt L et al. (2005) Heat shock protein (HSP) 60 from Bacteroides vulgatus stimulates proinflammatory cytokine production by rat splenocytes [abstract]. Gastroenterology 128: A512
• Sartor RB (2004) Microbial influences in inflammatory bowel disease: role in pathogenesis and clinical implications. In Kirsner's Inflammatory Bowel Diseases, 138–162 (Eds Sartor RB and Sandborn WJ) Philadelphia: Elsevier
  Google Scholar
• Kim SC et al. (2004) Dual-association of gnotobiotic IL-10−/− mice with two nonpathogenic commensal bacterial species accelerates colitis [abstract]. Gastroenterology 126: A291
• Tsang J and Sartor RB (2005) Effect of diet on colitis in IL-10−/− mice [abstract]. Gastroenterology 128: A210
  Google Scholar
• Dieleman LA et al. (2003) Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52: 370–376
  Article CAS PubMed PubMed Central Google Scholar
• Schultz M et al. (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10 deficient mice. Inflamm Bowel Dis 8: 71–80
  Article PubMed Google Scholar
• Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology 126: 1620–1633
  Article PubMed Google Scholar
• Bibiloni R et al. (2005) VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100: 1539–1546
  Article PubMed Google Scholar
• Kuisma J et al. (2003) Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 17: 509–515
  Article CAS PubMed Google Scholar
• Gionchetti P et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305–309
  Article CAS PubMed Google Scholar
• Berg DJ et al. (2002) Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 123: 1527–1542
  Article CAS PubMed Google Scholar
• Perl DP et al. (2004) Bacterial–metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis 10: 881–883
  Article PubMed Google Scholar
• Birrenbach T and Bocker U (2004) Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 10: 848–859
  Article PubMed Google Scholar
• Cosnes J (2004) Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 18: 481–496
  Article CAS PubMed Google Scholar
• Sartor RB (2005) Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut 54: 896–898
  Article PubMed PubMed Central Google Scholar
• Chiodini RJ et al. (1984) Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig Dis Sci 29: 1073–1079
  Article CAS PubMed Google Scholar
• Shafran I et al. (2002) Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis 34: 22–28
  Article CAS PubMed Google Scholar
• Millar D et al. (1996) IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales. Appl Env Microbiol 62: 3446–3452
  CAS Google Scholar
• Naser SA et al. (2000) Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am J Gastroenterol 95: 1094–1095
  Article CAS PubMed Google Scholar
• Naser SA et al. (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364: 1039–1044
  Article PubMed Google Scholar
• Autschbach F et al. (2005) High prevalence of Mycobacterium avium subsp. paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut 54: 944–999
  Article CAS PubMed PubMed Central Google Scholar
• Jubb TF and Galvin JW (2004) Effect of a test and control program for bovine Johne's disease in Victorian dairy herds 1992–2002. Aust Vet J 82: 228–232
  Article CAS PubMed Google Scholar
• Raizman EA et al. (2004) The distribution of Mycobacterium avium ssp. paratuberculosis in the environment surrounding Minnesota dairy farms. J Dairy Sci 87: 2959–2966
  Article CAS PubMed Google Scholar
• Lund BM et al. (2002) Pasteurization of milk and the heat resistance of Mycobacterium avium subsp. paratuberculosis: a critical review of the data. Int J Food Microbiol 77: 135–145
  Article PubMed Google Scholar
• Darfeuille-Michaud A et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412–421
  Article PubMed Google Scholar
• Peeters H et al. CARD15 variants determine a disturbed response of monocytes to adherent-invasive Escherichia coli LF82 in Crohn 2019's disease [abstract]. Ann NY Acad Sci, in press
• Liu Y et al. (1995) Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 108: 1396–1404
  Article CAS PubMed Google Scholar
• Darfeuille-Michaud A (2002) Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol 292: 185–193
  Article CAS PubMed Google Scholar
• Huycke MM et al. Superoxide production by Enterococcus faecalis upregulates NTN1 oncogene in the colonic epithelium and alters inflammation-associated gene expression [abstract]. Ann NY Acad Sci, in press
• Erichsen K et al. (2005) Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 11: 744–748
  Article PubMed Google Scholar
• Lerner A et al. (2006) Bacterial–aluminum interactions. The role of aluminum in bacterial-induced colitis in IL-10 deficient mice [abstract]. Gastroenterology 130: A362
  Google Scholar
• Summers RW et al. (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128: 825–832
  Article PubMed Google Scholar
• Summers RW et al. (2005) Trichuris suis therapy in Crohn's disease. Gut 54: 87–90
  Article CAS PubMed PubMed Central Google Scholar
• Elliott DE et al. (2004) Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 34: 2690–2698
  Article CAS PubMed Google Scholar
• Korzenik JR and Dieckgraefe BK (2000) Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 45: 1121–1129
  Article PubMed Google Scholar
• Korzenik JR et al. (2005) Sargramostim for active Crohn's disease. N Engl J Med 352: 2193–2201
  Article CAS PubMed Google Scholar
• Powrie F (2004) Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses. Ann NY Acad Sci 1029: 132–141
  Article CAS PubMed Google Scholar
• Elson CO et al. (2004) Gene disruption and immunity in experimental colitis. Inflamm Bowel Dis 10 (Suppl 1): S25–S28
  Article PubMed Google Scholar
• Allez M and Mayer L (2004) Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis 10: 666–676
  Article PubMed Google Scholar
• Bouma G and Strober W (2003). The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521–533
  Article PubMed CAS Google Scholar
• Fuss IJ et al. (2002) The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol 168: 900–908
  Article CAS PubMed Google Scholar
• Kraus TA et al. (2004) Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 126: 1771–1778
  Article CAS PubMed Google Scholar
• Monteleone G et al. (2001) Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J Clin Invest 108: 601–609
  Article CAS PubMed PubMed Central Google Scholar
• Powrie F et al. (1994) Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179: 589–600
  Article CAS PubMed Google Scholar
• Mottet C et al. (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170: 3939–3943
  Article CAS PubMed Google Scholar
• Albright C et al. (2002) Endogenous IL-10 inhibits APC stimulation of T lymphocyte responses to luminal bacteria [abstract]. Gastroenterology 122: A270
• Liu B et al. (2006) IL-10 production by both antigen presenting cells and CD4+ T lymphocytes maintains mucosal homeostasis [abstract]. Gastroenterology 130: A232
  Google Scholar
• Maeda S et al. (2005) Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307: 734–738
  Article CAS PubMed Google Scholar
• Rachmilewitz D et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520–528
  Article CAS PubMed Google Scholar
• Anant S et al. Plasmacytoid DCs are critical elements in the response to GM-CSF in the DSS colitis model [abstract]. Ann NY Acad Sci, in press
• Beckwith J et al. (2005) Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology 129: 1473–1484
  Article CAS PubMed Google Scholar
• Itoh J et al. (2001) Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 49: 35–41
  Article CAS PubMed PubMed Central Google Scholar
• Atreya R et al. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nat Med 6: 583–588
  Article CAS PubMed Google Scholar
• Peppelenbosch MP and van Deventer SJ (2004) T cell apoptosis and inflammatory bowel disease. Gut 53: 1556–1558
  Article PubMed CAS Google Scholar
• Tiede I et al. (2003) CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 111: 1133–1145
  Article CAS PubMed PubMed Central Google Scholar
• Doering J et al. (2004) Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. Gut 53: 1632–1638
  Article CAS PubMed PubMed Central Google Scholar
• Lugering A et al. (2001) Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 121: 1145–1157
  Article CAS PubMed Google Scholar
• ten Hove T et al. (2002) Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 50: 206–211
  Article CAS PubMed PubMed Central Google Scholar
• Van den Brande JM et al. (2003) Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 124: 1774–1785
  Article CAS PubMed Google Scholar
• Selby W (2005) Antibiotic therapy for Crohn's disease. Presented at 9th Annual Coolum Update in Gastroenterology and Hepatology: 2005 June 11–13; Coolum
  Google Scholar